Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study will be offered to patients with non-small cell lung carcinoma diagnosed at stage IV and receiving first-line treatment. The patient will benefit from a complete assessment at inclusion (clinical exam, imagery, biological exam, dietary consultation, test LFQP. At the end of this 1st evaluation, patients in whom the diagnosis of undernutrition is made will benefit from dietary management with personalized advice that will take into account the symptoms of cancer, the possible side effects of treatments as well as the social environment. Every two cures, i.e. every 4 to 6 weeks, these examens will be performed until the occurrence of an event (progression of the disease according to the RECIST criteria, death or change of therapeutic line). At the end of these assessments, patients will benefit from dietary management with a readjustment of personalized advice that will take into account the difficulties highlighted during the assessment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular tyrosine kinase inhibitors) according to current French recommendations.

• Age over 18 and under 70

• Patient speaking and reading French fluently

• Affiliation to a social security scheme

• Patient able and willing to follow all study procedures in accordance with the protocol

• Patient having understood, signed and dated the consent form

Locations
Other Locations
France
Centre Georges-François Leclerc
RECRUITING
Dijon
Contact Information
Primary
Sophie rs BETTING
sbetting@cgfl.fr
0(3) 45 34 81 08
Backup
Marjolaine rs GEORGES, Pr
marjolaine.georges@chu-dijon.fr
0(3) 80 29 37 72
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 190
Treatments
Other: All patients included in the study
Patient with stage IV non-small cell bronchopulmonary carcinoma receiving first-line treatment and received LFQP questionnaire
Sponsors
Leads: Centre Georges Francois Leclerc

This content was sourced from clinicaltrials.gov

Similar Clinical Trials